​​​Trautec stands at the forefront of innovation, dedicated to the development of medicine-oriented recombinant human collagen (SRHC). Their mission revolves around making SRHC universally accessible, ensuring its widespread accessibility and adaptability, especially within the personal care industry, with a primary focus on the cosmetics and medical regeneration sectors. Trautec is committed to delivering a sustainable, collagen-based biomaterial that is both effective and safe.

To learn more about Trautec, visit their website: https://www.trautec.us/